cyclic adp-ribose has been researched along with medetomidine in 1 studies
| Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) | Studies (medetomidine) | Trials (medetomidine) | Recent Studies (post-2010) (medetomidine) |
|---|---|---|---|---|---|
| 758 | 0 | 144 | 1,335 | 296 | 444 |
| Protein | Taxonomy | cyclic adp-ribose (IC50) | medetomidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guedes, AG; Kannan, MS; Rude, EP | 1 |
1 other study(ies) available for cyclic adp-ribose and medetomidine
| Article | Year |
|---|---|
Potential role of the CD38/cADPR signaling pathway as an underlying mechanism of the effects of medetomidine on insulin and glucose homeostasis.
Topics: ADP-ribosyl Cyclase 1; Adrenergic alpha-2 Receptor Agonists; Animals; Cyclic ADP-Ribose; Female; Gene Expression Regulation; Glucose; Homeostasis; Insulin; Male; Medetomidine; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction | 2013 |